Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dyad Medical has developed an FDA-cleared cloud-based AI platform—Libby™ IAAA—for automated analysis of intravascular optical coherence tomography images to assist clinicians with rapid, accurate cardiac image interpretation. The technology enables real-time expert-level diagnostic support globally and aims to improve outcomes in coronary artery disease by optimizing stent placement and reducing manual workload.
No traditional clinical trial results as it’s a device/software company; regulatory milestone includes FDA clearance for its core product.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dyad Medical.